研究报告 |
|
|
|
|
通过SRC3敲低改善糖尿病肾病肾功能紊乱的实验研究* |
周鑫帝,甘淳,陈婉冰,李秋**() |
重庆医科大学附属儿童医院 国家儿童健康与疾病临床医学研究中心 儿童发育疾病研究教育部重点实验室 儿科学重庆市重点实验室 重庆 400014 |
|
Experimental Study on Improvement of Renal Dysfunction in Diabetic Kidney Disease by SRC3 Knockdown |
Xin-di ZHOU,Chun GAN,Wan-bing CHEN,Qiu LI**() |
Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disease, Key Laboratory of Child Development and Disorders(Ministry of Education ), Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China |
引用本文:
周鑫帝, 甘淳, 陈婉冰, 李秋. 通过SRC3敲低改善糖尿病肾病肾功能紊乱的实验研究*[J]. 中国生物工程杂志, 2023, 43(7): 23-35.
Xin-di ZHOU, Chun GAN, Wan-bing CHEN, Qiu LI. Experimental Study on Improvement of Renal Dysfunction in Diabetic Kidney Disease by SRC3 Knockdown. China Biotechnology, 2023, 43(7): 23-35.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2301029
或
https://manu60.magtech.com.cn/biotech/CN/Y2023/V43/I7/23
|
[1] |
Magliano D, Boyko E. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation, 2021: 37.
|
[2] |
Umanath K, Lewis J B. Update on diabetic nephropathy: core curriculum 2018. American Journal of Kidney Diseases, 2018, 71(6): 884-895.
doi: S0272-6386(17)31102-2
pmid: 29398179
|
[3] |
党佳蓉, 党琳慧, 郭煦妍, 等. 糖尿病肾病的发病机制研究. 医学信息, 2022, 35(17): 161-165.
|
|
Dang J R, Dang L H, Guo X Y, et al. Study on pathogenesis of diabetic nephropathy. Medical Information, 2022, 35(17): 161-165.
|
[4] |
冯显. 中西医治疗糖尿病肾病的研究概况. 中国民族民间医药, 2022, 31(11): 46-49.
|
|
Feng X. Study on the treatment of diabetic nephropathy by traditional Chinese and western medicine. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2022, 31(11): 46-49.
|
[5] |
Li L C, Deng C X, Chen Q. SRC-3, a steroid receptor coactivator: implication in cancer. International Journal of Molecular Sciences, 2021, 22(9): 4760.
doi: 10.3390/ijms22094760
|
[6] |
Anzick S L, Kononen J, Walker R L, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 1997, 277(5328): 965-968.
doi: 10.1126/science.277.5328.965
pmid: 9252329
|
[7] |
Liao L, Kuang S Q, Yuan Y H, et al. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. The Journal of Steroid Biochemistry and Molecular Biology, 2002, 83(1-5): 3-14.
doi: 10.1016/S0960-0760(02)00254-6
|
[8] |
Liu M Y, Guo H P, Hong C Q, et al. Up-regulation of nuclear receptor coactivator amplified in breast cancer-1 in papillary thyroid carcinoma correlates with lymph node metastasis. Clinical and Translational Oncology, 2013, 15(11): 947-952.
doi: 10.1007/s12094-013-1029-x
|
[9] |
Tanner M M, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q 13 in ovarian cancer. Clinical Cancer Research, 2000, 6(5): 1833-1839.
pmid: 10815905
|
[10] |
Balmer N N, Richer J K, Spoelstra N S, et al. Steroid receptor coactivator AIB 1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers. Modern Pathology, 2006, 19(12): 1593-1605.
doi: 10.1038/modpathol.3800696
|
[11] |
Zhao Z F, Zhou S G, Li W Y, et al. AIB1 predicts tumor response to definitive chemoradiotherapy and prognosis in cervical squamous cell carcinoma. Journal of Cancer, 2019, 10(21): 5212-5222.
doi: 10.7150/jca.31697
pmid: 31602272
|
[12] |
Ma L Y, Liu W P, Xu A, et al. Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect. Cancer Science, 2020, 111(6): 2028-2040.
doi: 10.1111/cas.14412
pmid: 32279388
|
[13] |
Dasgupta S, Rajapakshe K, Zhu B K, et al. Metabolic enzyme PFKFB 4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature, 2018, 556(7700): 249-254.
doi: 10.1038/s41586-018-0018-1
|
[14] |
Wang J J, Zou J X, Xue X Q, et al. ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nature Medicine, 2016, 22(5): 488-496.
doi: 10.1038/nm.4070
pmid: 27019329
|
[15] |
Coste A, Louet J F, Lagouge M, et al. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(44): 17187-17192.
|
[16] |
York B, Yu C D, Sagen J V, et al. Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(24): 11122-11127.
|
[17] |
Wang W Y, Gu H B, Li W H, et al. SRC-3 knockout attenuates myocardial injury induced by chronic intermittent hypoxia in mice. Oxidative Medicine and Cellular Longevity, 2021, 2021: 6372430.
|
[18] |
李佳, 李莹, 尹扬光, 等. 类固醇受体辅活化子-3在急性胰腺炎患者外周血中的表达及意义. 重庆医学, 2010, 39(15): 1995-1997.
|
|
Li J, Li Y, Yin Y G, et al. Expression and significance of steroid receptor coactivator-3 in the acute pancreatitis. Chongqing Medicine, 2010, 39(15): 1995-1997.
|
[19] |
李军, 粟永萍, 王军平, 等. 类固醇受体辅活化子-3基因敲除对炎症反应中糖皮质激素受体的影响. 中国急救医学, 2008, 28(11): 994-998.
|
|
Li J, Su Y P, Wang J P, et al. Effect of steroid receptor coactivator-3 knock-out on GR during the inflammatory response. Chinese Journal of Critical Care Medicine, 2008, 28(11): 994-998.
|
[20] |
李雯翀, 朱咏瑶, 刘枘岢, 等. 血清分泌型卷曲相关蛋白4、血管生成抑制蛋白-1对早期2型糖尿病肾病的诊断价值. 中国医刊, 2022, 57(10): 1124-1127.
|
|
Li W C, Zhu Y Y, Liu R K, et al. Diagnostic value of serum secretory curl related protein 4 and angiogenesis inhibitory protein-1 in early type 2 diabetic nephropathy. Chinese Journal of Medicine, 2022, 57(10): 1124-1127.
|
[21] |
Sanajou D, Ghorbani Haghjo A, Argani H, et al. AGE-RAGE axis blockade in diabetic nephropathy: current status and future directions. European Journal of Pharmacology, 2018, 833: 158-164.
doi: S0014-2999(18)30319-4
pmid: 29883668
|
[22] |
Opazo-Ríos L, Mas S, Marín-Royo G, et al. Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. International Journal of Molecular Sciences, 2020, 21(7): 2632.
doi: 10.3390/ijms21072632
|
[23] |
Gómez-Jaramillo L, Cano-Cano F, Sánchez-Fernández E M, et al. Unravelling the inflammatory processes in the early stages of diabetic nephropathy and the potential effect of (ss)-DS-ONJ. International Journal of Molecular Sciences, 2022, 23(15): 8450.
doi: 10.3390/ijms23158450
|
[24] |
刘嘉, 严宝飞, 张景正, 等. 黄芩汤对糖尿病肾病大鼠肾脏NF-κB/NLRP3/Caspase-1细胞焦亡通路的影响. 中国生物工程杂志, 2022, 42(11): 109-116.
|
|
Liu J, Yan B F, Zhang J Z, et al. Effect of huangqin decoction on NF-κB/NLRP3/caspase-1 signaling pathway and pyroptosis in kidney of diabetic nephropathy rats. China Biotechnology, 2022, 42(11): 109-116.
|
[25] |
张皓, 倪敏, 张慧, 等. 糖尿病肾病患者外周血NOD样受体蛋白3炎症小体变化及其临床意义. 中华内分泌外科杂志, 2022, 16(4): 479-484.
|
|
Zhang H, Ni M, Zhang H, et al. Changes of NOD-like receptor family pyrin domain-containing protein 3 inflammasomes in peripheral blood of patients with diabetic nephropathy and its clinical significance. Chinese Journal of Endocrine Surgery, 2022, 16(4): 479-484.
|
[26] |
Yang X Q, Wang Y G, Gao G Q. High glucose induces rat mesangial cells proliferation and MCP-1 expression via ROS-mediated activation of NF-κB pathway, which is inhibited by eleutheroside E. Journal of Receptor and Signal Transduction Research, 2016, 36(2): 152-157.
doi: 10.3109/10799893.2015.1061002
pmid: 26644089
|
[27] |
陈淑娟, 周丽明, 李明政, 等. LncRNA ANRIL/miR-122-5p轴在高糖诱导足细胞炎症及氧化应激中的作用及机制. 国际免疫学杂志, 2022, 45(5): 464-469.
|
|
Chen S J, Zhou L M, Li M Z, et al. Role and mechanism of LncRNA ANRIL/miR-122-5p axis in high glucose induced podocyte inflammation and oxidative stress. International Journal of Immunology, 2022, 45(5): 464-469.
|
[28] |
李海燕, 杨彦平, 刘国. lncRNA PACER对高糖诱导的人肾小管上皮细胞中炎性因子表达和转分化的影响. 中国药师, 2021, 24(9): 1647-1651.
|
|
Li H Y, Yang Y P, Liu G. Effects of lncRNA PACER on the expressions of inflammatory factors and transdifferentiation in human renal tubular epithelial cells induced by high glucose. China Pharmacist, 2021, 24(9): 1647-1651.
|
[29] |
Stashi E, York B, O’Malley B W. Steroid receptor coactivators: servants and masters for control of systems metabolism. Trends in Endocrinology and Metabolism: TEM, 2014, 25(7): 337-347.
doi: 10.1016/j.tem.2014.05.004
|
[30] |
Ma X R, Xu L Y, Wang S, et al. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. Journal of Hepatology, 2011, 55(2): 445-452.
doi: 10.1016/j.jhep.2010.11.022
pmid: 21184786
|
[31] |
Li J, Liu Y H, Ou S, et al. Steroid receptor coactivator-3 differentially regulates the inflammatory response in peritoneal macrophages. Molecular Medicine Reports, 2012, 5(4): 1099-1105.
doi: 10.3892/mmr.2012.750
|
[32] |
杜智勇, 粟永萍, 徐建明, 等. 严重烧伤对SRC-3基因敲除小鼠肝脏NF-κB表达及核转位的影响. 第三军医大学学报, 2006, 28(8): 743-745.
|
|
Du Z Y, Su Y P, Xu J M, et al. Effect of burn injury on expression and nuclear translocation of NF-κB in SRC-3 knock out mice. Journal of Army Medical University, 2006, 28(8): 743-745.
|
[33] |
Reidy K, Kang H M, Hostetter T, et al. Molecular mechanisms of diabetic kidney disease. The Journal of Clinical Investigation, 2014, 124(6): 2333-2340.
doi: 10.1172/JCI72271
|
[34] |
Szkudelski T. Streptozotocin-nicotinamide-induced diabetes in the rat, characteristics of the experimental model. Experimental Biology and Medicine, 2012, 237(5): 481-490.
doi: 10.1258/ebm.2012.011372
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|